AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24080948 — intervention group
Group type: COMPARATOR
Intervention: Automatic tests (manual pure-tone air conduction audiometry and bone conduction audiometry)
Number of subjects: 120
Study 24080948 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic test battery
Number of subjects: 120
Study 23149085 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastroretentive gabapentin (G‐GR) 1800mg
Number of subjects: 721
Study 23149085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 721
Study 20494655 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary delivery of abciximab (0.25 mg/kg)
Number of subjects: 105
Study 20494655 — intervention group
Group type: COMPARATOR
Intervention: Intravenous delivery of abciximab (0.25 mg/kg)
Number of subjects: 105
Study 20494655 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose abciximab (>=0.30 mg/kg)
Number of subjects: 105
Study 20494655 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose abciximab (0.25 mg/kg)
Number of subjects: 105
Study 20494655 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary delivery of abciximab
Number of subjects: 105
Study 20494655 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose abciximab
Number of subjects: 105
Study 20494655 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical, angiographic and cardiac magnetic resonance imaging outcomes at 6 and 12 months
Number of subjects: 105
Study 18632765 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifocal right ventricular pacing (apical and outflow tract)
Number of subjects: 0
Study 18632765 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple site pacing (right ventricular apex, outflow tract, and lateral left ventricular pacing)
Number of subjects: 0
Study 15689724 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills-based treatment protocol
Number of subjects: 39
Study 15689724 — intervention group
Group type: COMPARATOR
Intervention: Supportive relationship therapy
Number of subjects: 39
Study 14520034 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic whiplash‐associated disorders group
Number of subjects: 34
Study 14520034 — intervention group
Group type: COMPARATOR
Intervention: Chronic insidious onset neck pain group
Number of subjects: 34
Study 14520034 — intervention group
Group type: EXPERIMENTAL
Intervention: C3-C4 segment in whiplash‐associated disorders group
Number of subjects: 34
Study 14520034 — intervention group
Group type: EXPERIMENTAL
Intervention: C5-C6 segment in whiplash‐associated disorders group
Number of subjects: 34
Study 14520034 — intervention group
Group type: EXPERIMENTAL
Intervention: C3-C4 segment in insidious onset neck pain group
Number of subjects: 34
Study 10098817 — intervention group
Group type: EXPERIMENTAL
Intervention: Head Mounted Displays (HMDs)
Number of subjects: 0
Study 8679346 — intervention group
Group type: EXPERIMENTAL
Intervention: 7% sevoflurane in 66% nitrous oxide in oxygen
Number of subjects: 120
Study 8679346 — intervention group
Group type: COMPARATOR
Intervention: 3% halothane in 66% nitrous oxide in oxygen
Number of subjects: 120
Study 2052467 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 10 mg daily
Number of subjects: 25
Study 2052467 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg daily plus hydrochlorothiazide 25 mg daily
Number of subjects: 25
Study 2052467 — intervention group
Group type: COMPARATOR
Intervention: Enalapril monotherapy
Number of subjects: 25
Study 2052467 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 25
Study 6137785 — intervention group
Group type: EXPERIMENTAL
Intervention: Lormetazepam (0.5 mg)
Number of subjects: 94
Study 6137785 — intervention group
Group type: COMPARATOR
Intervention: Triazolam (0.5 mg)
Number of subjects: 94
Study 30975106 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (high intervention dose)
Number of subjects: 215
Study 30975106 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (boys beyond the 95th percentile)
Number of subjects: 215
Study 30975106 — intervention group
Group type: COMPARATOR
Intervention: Intervention group (overall)
Number of subjects: 215
Study 30975106 — intervention group
Group type: COMPARATOR
Intervention: Intervention group (girls)
Number of subjects: 215
Study 27743846 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocal Loading Task (VLT)
Number of subjects: 50
Study 27743846 — intervention group
Group type: EXPERIMENTAL
Intervention: Work
Number of subjects: 50
Study 27743846 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure
Number of subjects: 50
Study 27743846 — intervention group
Group type: COMPARATOR
Intervention: Control (voice healthy)
Number of subjects: 50
Study 25293966 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive detached mindfulness therapy
Number of subjects: 45
Study 25293966 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management training
Number of subjects: 45
Study 25293966 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 45
Study 25058771 — intervention group
Group type: EXPERIMENTAL
Intervention: ULTRAPRO Hernia System (UHS)
Number of subjects: 99
Study 25058771 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein technique (group L)
Number of subjects: 99
Study 21681817 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 60
Study 21681817 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 19848201 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenmai Injection (SMI)
Number of subjects: 40
Study 19848201 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 17464731 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine
Number of subjects: 30
Study 17464731 — intervention group
Group type: COMPARATOR
Intervention: Divalproex
Number of subjects: 30
Study 15665959 — intervention group
Group type: EXPERIMENTAL
Intervention: Refracterin therapy
Number of subjects: 0
Study 15665959 — intervention group
Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 0
Study 11164404 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (nailed group)
Number of subjects: 27
Study 11164404 — intervention group
Group type: COMPARATOR
Intervention: Plaster cast (casted group)
Number of subjects: 27
Study 9129897 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous digoxin (mean dose 0.88 ± 0.35 mg)
Number of subjects: 239
Study 9129897 — intervention group
Group type: COMPARATOR
Intervention: Placebo (mean dose 0.96 ± 0.37 mg)
Number of subjects: 239
Study 8186114 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol solution (50 micrograms/ml), applied twice daily for 4 weeks
Number of subjects: 49
Study 8186114 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle solution), applied twice daily for 4 weeks
Number of subjects: 49
Study 8186114 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol solution
Number of subjects: 49
Study 8186114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 8186114 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol solution and Placebo
Number of subjects: 49
Study 2451930 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance P (SP)
Number of subjects: 6
Study 2451930 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurokinin A (NKA)
Number of subjects: 6
Study 30779061 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibacterial-coated sutures (CHX-coated)
Number of subjects: 36
Study 30779061 — intervention group
Group type: COMPARATOR
Intervention: Uncoated sutures (Control)
Number of subjects: 36
Study 29261242 — intervention group
Group type: EXPERIMENTAL
Intervention: ED-based care coordination intervention
Number of subjects: 72
Study 29261242 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 72
Study 26687552 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 200 mg
Number of subjects: 15
Study 26687552 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 15
Study 25291974 — intervention group
Group type: EXPERIMENTAL
Intervention: sifuvirtide 10 mg q.d. for 28 days
Number of subjects: 27
Study 25291974 — intervention group
Group type: EXPERIMENTAL
Intervention: sifuvirtide 20 mg q.d. for 28 days
Number of subjects: 27
Study 25291974 — intervention group
Group type: EXPERIMENTAL
Intervention: sifuvirtide 20 mg q.d. in combination with HAART for 168 days
Number of subjects: 27
Study 25291974 — intervention group
Group type: COMPARATOR
Intervention: sifuvirtide (both doses)
Number of subjects: 27
Study 21902704 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (100 mg)
Number of subjects: 100
Study 21902704 — intervention group
Group type: EXPERIMENTAL
Intervention: Novafen (325 mg paracetamol, 200 mg ibuprofen, 40 mg caffeine anhydrous)
Number of subjects: 100
Study 21902704 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg)
Number of subjects: 100
Study 21902704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 18814935 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine 25 mg with metoclopramide 10 mg
Number of subjects: 286
Study 18814935 — intervention group
Group type: COMPARATOR
Intervention: Placebo with metoclopramide 10 mg
Number of subjects: 286
Study 18814935 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine 25 mg with metoclopramide 20 mg
Number of subjects: 286
Study 18814935 — intervention group
Group type: COMPARATOR
Intervention: Placebo with metoclopramide 20 mg
Number of subjects: 286
Study 18814935 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 286
Study 18814935 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg
Number of subjects: 286
Study 17437152 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (50 mg/kg in 100 ml of saline, followed by 8 mg/kg/h infusion)
Number of subjects: 60
Study 17437152 — intervention group
Group type: COMPARATOR
Intervention: Saline (equal volume before induction and 8 mg/kg/h infusion)
Number of subjects: 60
Study 15542186 — intervention group
Group type: EXPERIMENTAL
Intervention: StaphVAX
Number of subjects: 100
Study 11435842 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal oxybutynin
Number of subjects: 76
Study 11435842 — intervention group
Group type: COMPARATOR
Intervention: Oral oxybutynin
Number of subjects: 76
Study 9777792 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene plus medium- or high-potency corticosteroid
Number of subjects: 0
Study 9777792 — intervention group
Group type: COMPARATOR
Intervention: Tazarotene plus placebo cream
Number of subjects: 0
Study 7625470 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright white light (600-lux)
Number of subjects: 57
Study 7625470 — intervention group
Group type: EXPERIMENTAL
Intervention: Dim red light (30-lux)
Number of subjects: 57
Study 2199132 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 0
Study 900433 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 200
Study 900433 — intervention group
Group type: COMPARATOR
Intervention: Propanidid (7 mg/kg)
Number of subjects: 200
Study 900433 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate with faster injection rate (15 seconds)
Number of subjects: 200
Study 900433 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate without atropine premedication
Number of subjects: 200
Study 31964172 — intervention group
Group type: EXPERIMENTAL
Intervention: Case manager-assisted rehabilitation
Number of subjects: 82
Study 31964172 — intervention group
Group type: COMPARATOR
Intervention: Control group (no case manager-assisted rehabilitation)
Number of subjects: 82
Study 31631093 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pathway (CP)
Number of subjects: 62
Study 31631093 — intervention group
Group type: COMPARATOR
Intervention: No clinical pathway
Number of subjects: 62
Study 27837201 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% sirolimus gel
Number of subjects: 36
Study 27837201 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% sirolimus gel (adults)
Number of subjects: 36
Study 27837201 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% sirolimus gel (adults)
Number of subjects: 36
Study 27837201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 25951755 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 1 mg
Number of subjects: 194
Study 25951755 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 5 mg
Number of subjects: 194
Study 25951755 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 25 mg
Number of subjects: 194
Study 25951755 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 12.5 mg
Number of subjects: 194
Study 25951755 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study 24267640 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoFlex tube
Number of subjects: 60
Study 24267640 — intervention group
Group type: COMPARATOR
Intervention: Standard endotracheal tube with intubation stylet
Number of subjects: 60
Study 22017672 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined relaxation (applied tension release, ATR) and specific shooting training for 10 weeks
Number of subjects: 12
Study 22017672 — intervention group
Group type: COMPARATOR
Intervention: Control group (no special training intervention)
Number of subjects: 12
Study 19554676 — intervention group
Group type: EXPERIMENTAL
Intervention: Threpsology support
Number of subjects: 0
Study 17724727 — intervention group
Group type: EXPERIMENTAL
Intervention: seminal vesical‐prostatic base blockade
Number of subjects: 243
Study 17724727 — intervention group
Group type: EXPERIMENTAL
Intervention: intraprostatic blockade
Number of subjects: 243
Study 17724727 — intervention group
Group type: EXPERIMENTAL
Intervention: apical‐rectal blockade
Number of subjects: 243
Study 15121563 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate
Number of subjects: 191
Study 15121563 — intervention group
Group type: EXPERIMENTAL
Intervention: Desogestrel pills
Number of subjects: 191
Study 15121563 — intervention group
Group type: COMPARATOR
Intervention: Nonhormonal contraception (control)
Number of subjects: 191
Study 11273796 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide (400 microg)
Number of subjects: 15
Study 11273796 — intervention group
Group type: COMPARATOR
Intervention: Budesonide (400 microg)
Number of subjects: 15
Study 9509441 — intervention group
Group type: COMPARATOR
Intervention: Dihydralazine
Number of subjects: 26
Study 9509441 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil
Number of subjects: 26
Study 8138836 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-treated group (most severely ill)
Number of subjects: 0
Study 8138836 — intervention group
Group type: COMPARATOR
Intervention: Control-treated group (least severely ill)
Number of subjects: 0
Study 8138836 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomly assigned group (moderately ill)
Number of subjects: 0
Study 2259898 — intervention group
Group type: EXPERIMENTAL
Intervention: OM-8980
Number of subjects: 40
Study 2259898 — intervention group
Group type: COMPARATOR
Intervention: D-penicillamine
Number of subjects: 40
Study 913230 — intervention group
Group type: EXPERIMENTAL
Intervention: Butaclamol (BT) 10 mg
Number of subjects: 0
Study 913230 — intervention group
Group type: EXPERIMENTAL
Intervention: Butaclamol (BT) 20 mg
Number of subjects: 0
Study 913230 — intervention group
Group type: EXPERIMENTAL
Intervention: Butaclamol (BT) 40 mg
Number of subjects: 0
Study 913230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31833394 — intervention group
Group type: EXPERIMENTAL
Intervention: Isatuximab plus carfilzomib/dexamethasone
Number of subjects: 302
Study 31833394 — intervention group
Group type: COMPARATOR
Intervention: Carfilzomib/dexamethasone
Number of subjects: 302
Study 30734717 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid at a daily dose of 500 mg
Number of subjects: 0
Study 30734717 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid at a daily dose of 750 mg
Number of subjects: 0
Study 30734717 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid at a daily dose of 1,000 mg
Number of subjects: 0
Study 30734717 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid at a daily dose of 1,500 mg
Number of subjects: 0
Study 28490529 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.58 μmol NaNO2·kg‐1·h‐1
Number of subjects: 12
Study 28490529 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.74 μmol NaNO2·kg‐1·h‐1
Number of subjects: 12
Study 28490529 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.48 μmol NaNO2·kg‐1·h‐1
Number of subjects: 12
Study 28490529 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 12
Study 24921623 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinach supplementation (1 g/kg body weight daily for 14 days)
Number of subjects: 20
Study 24921623 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinach supplementation
Number of subjects: 20
Study 24921623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 23505168 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean Diet without weight loss (MedDiet - WL)
Number of subjects: 26
Study 23505168 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean Diet with weight loss (MedDiet + WL)
Number of subjects: 26
Study 16971664 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus Treosulfan (GeT)
Number of subjects: 48
Study 16971664 — intervention group
Group type: COMPARATOR
Intervention: Treosulfan alone (T)
Number of subjects: 48
Study 12559179 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard pancreaticoduodenectomy
Number of subjects: 299
Study 12559179 — intervention group
Group type: COMPARATOR
Intervention: Radical pancreaticoduodenectomy
Number of subjects: 299
Study 10562261 — intervention group
Group type: EXPERIMENTAL
Intervention: Early dipyridamole (99m)Tc-sestamibi MPI study
Number of subjects: 451
Study 10562261 — intervention group
Group type: COMPARATOR
Intervention: Submaximal exercise (99m)Tc-sestamibi MPI study
Number of subjects: 451
Study 8724947 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based interactive methods (including touchscreen)
Number of subjects: 0
Study 8724947 — intervention group
Group type: COMPARATOR
Intervention: Original paper-and-pencil format
Number of subjects: 0
Study 1996571 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) 100 U/kg
Number of subjects: 20
Study 1996571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6662170 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg of long acting (L.A.) propranolol
Number of subjects: 15
Study 6662170 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of sustained action (S.A.) metoprolol
Number of subjects: 15
Study 6662170 — intervention group
Group type: COMPARATOR
Intervention: Matched placebos
Number of subjects: 15
Study 31705620 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Involvement of Users in Research Observation Schedule and Questionnaire
Number of subjects: 0
Study 31705620 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31318033 — intervention group
Group type: EXPERIMENTAL
Intervention: Western diet high-fat meal plus postprandial walking (WD-W)
Number of subjects: 26
Study 31318033 — intervention group
Group type: COMPARATOR
Intervention: Western diet high-fat meal plus postprandial resting (WD-R)
Number of subjects: 26
Study 31318033 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean-type diet meal plus postprandial walking (MD-W)
Number of subjects: 26
Study 31318033 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean-type diet meal plus postprandial resting (MD-R)
Number of subjects: 26
Study 31318033 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean-type diet meal
Number of subjects: 26
Study 31318033 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial walking
Number of subjects: 26
Study 28240186 — intervention group
Group type: EXPERIMENTAL
Intervention: Tender coconut water (TCW) 300 ml twice daily for 14 days
Number of subjects: 32
Study 28240186 — intervention group
Group type: COMPARATOR
Intervention: Water 300 ml twice daily for 14 days
Number of subjects: 32
Study 24524383 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-based nutrition program (vegan diet) for 18 weeks
Number of subjects: 292
Study 22981898 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie Restriction (CR) - sustained 25% calorie restriction
Number of subjects: 238
Study 22981898 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 238
Study 21593117 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 27
Study 19879499 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased frequency of self-weighing
Number of subjects: 63
Study 19879499 — intervention group
Group type: COMPARATOR
Intervention: Maintained or decreased frequency of self-weighing
Number of subjects: 63
Study 19879499 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-weighing frequency
Number of subjects: 63
Study 16813179 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with consciousness‐restoring resuscitation method (Group A)
Number of subjects: 120
Study 16813179 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with traditional acupuncture (Group B)
Number of subjects: 120
Study 16813179 — intervention group
Group type: COMPARATOR
Intervention: Traditional acupuncture (Group C)
Number of subjects: 120
Study 12653872 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple risk factor intervention
Number of subjects: 32
Study 12653872 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32
Study 12653872 — intervention group
Group type: EXPERIMENTAL
Intervention: Echogenic plaques intervention
Number of subjects: 32
Study 12653872 — intervention group
Group type: COMPARATOR
Intervention: Echogenic plaques usual care
Number of subjects: 32
Study 12653872 — intervention group
Group type: EXPERIMENTAL
Intervention: No plaques intervention
Number of subjects: 32
Study 12653872 — intervention group
Group type: COMPARATOR
Intervention: No plaques usual care
Number of subjects: 32